23.3 C
New York
Thursday, September 23, 2021

AngioDynamics Inc. (ANGO) stock rises during the after-hour session. Why is it so?

AngioDynamics Inc. (ANGO) stock declined by 1.37% during the last trading close whereas the ANGO stock rises by 16.08% in the after-hours trading session. The change in the stock is mainly due to quarterly results that the company is supposed to announce today i-e March 30, 2021. AngioDynamics is a leading manufacturer of advanced, minimally invasive medical instruments for vascular access, peripheral vascular disease, and oncology that are used by skilled healthcare professionals. ANGO has a variety of products such as market-leading ablation systems, vascular access products, and few others as well.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Analyst’s Expectations

The financial results of quarter ended on February 2021 is expected to be released by ANGO in no time. The analysts have given their consensus estimate regarding the financial results while in most of the cases if any certain company surpasses the consensus estimate the share price rises and in the opposite case the share price declines.

In the case of AngioDynamics, it is expected to report a quarterly EPS loss of $0.02 on revenue of $68.95 million, according to analysts covering ANGO. AngioDynamics posted $0.01 earnings per share on $69.78 million in sales in the same period last year. Also the analyst consensus estimate is expected to show a downfall of 300% in ANGO’s earning. While the revenue of ANGO would be low by 1.19% compared to the same quarter last year.


Any stock to move higher or lower may not be entirely due to an earnings beat or miss. Despite an earnings beat, many stocks lose ground as a result of other factors that disappoint investors. Unexpected catalysts have also helped a variety of stocks benefit despite an earnings miss. On the other hand, AngioDynamics does not seem to be a good candidate for an earnings beat. However, before betting on this stock or staying away from it ahead of its earnings report, investors should consider a number of other factors.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.